Comments
Shares of agri-biotechnology major Monsanto India fell by 4 per cent today after fair trade regulator CCI ordered a detailed probe against its US-parent joint venture Mahyco Monsanto Biotech India Ltd (MMBL).
Finding prima-facie violation of the competition law, CCI has ordered a detailed probe into alleged abuse of dominance by the Indian arm of the US-based genetically modified seed giant Monsanto.
The stock fell by 3.99 per cent to Rs 1,900.20 — its 52-week low — on the BSE.
On NSE, it slipped 3.37 per cent to hit a one-year low of Rs 1,910.
The majority order passed by six out of seven members including Chairman of the Competition Commission, follows two separate complaints filed against Mahyco Monsanto Biotech India Ltd (MMBL) — one by the Agriculture Ministry and another by three domestic seed companies — alleging abuse of dominance in the country’s Bt cotton seeds market.
The ministry had referred to the Competition Commission of India complaints filed against MMBL, including about “abuse of dominant position by charging unreasonably high trait fees (royalty) for Bt cotton seeds”.
Mahyco Monsato Biotech has said it will cooperate with the investigation by CCI and expressed confidence that the allegation against the company relating to abuse of dominance would be “ultimately dismissed”.
MMBL is a 50-50 joint venture between Monsanto and Mahyco.
Monsanto India is a subsidiary of US-based Monsanto, engaged in selling agri-inputs.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.